Novo Nordisk wins Dutch court order against Ceban over semaglutide
Go back to Novo Nordisk wins Dutch court order against Ceban over semaglutide| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.66 +0.59 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.07 | 52 Week High | $59.00 | |||
| Open | $43.66 | 52 Week Low | $32.80 | |||
| Day High | $43.71 | P/E | N/A | |||
| Day Low | $43.07 | EPS | $0.00 | |||
| Volume | 3,844,347 | |||||
